U.S. revives avian influenza vaccine plan
9 January, 2025
The United States is renewing its bird flu vaccine strategy as the virus continues to severely impact poultry and dairy industries, causing the deaths of over 130 million birds and leading to human infections. The USDA remains cautious about widespread vaccine use due to potential trade complications. Previously, vaccine stockpiles expired unused due to low demand. In response to the ongoing outbreak that began in early 2022, the USDA has announced plans to restock vaccines tailored for the current strains affecting both commercial and wild bird populations.
